Medcolcanna Organics Inc. Stock Toronto S.E.
Equities
MCCN
CA58406X1050
Pharmaceuticals
Sales 2019 | 1.58K 1.15K | Sales 2020 | 95.77K 69.62K | Capitalization | 8.09M 5.88M |
---|---|---|---|---|---|
Net income 2019 | -7M -5.09M | Net income 2020 | -7M -5.09M | EV / Sales 2019 | 4,531 x |
Net cash position 2019 | 2.32M 1.69M | Net Debt 2020 | 2.98M 2.16M | EV / Sales 2020 | 116 x |
P/E ratio 2019 |
-1.04
x | P/E ratio 2020 |
-1
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 41.37% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | 19-05-16 | |
Christopher Reid
DFI | Director of Finance/CFO | 46 | 19-05-16 |
Ana María Borda
CTO | Chief Tech/Sci/R&D Officer | - | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Metcalfe
CHM | Chairman | 84 | 19-05-16 |
Christopher Reid
DFI | Director of Finance/CFO | 46 | 19-05-16 |
Chief Executive Officer | 44 | 19-05-16 |
1st Jan change | Capi. | |
---|---|---|
+23.41% | 3.74B | |
+117.23% | 2.18B | |
+68.25% | 55.17M | |
+265.38% | 54.09M |